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ABSTRACT 
 
Julia E. Rasmussen:  Title 
(Under the direction of James M. Anderson) 
 
 Epithelia create barriers and regulate solute and water transport through 
transcellular and paracellular pathways.  The paracellular pathways of different 
tissues vary remarkably in size selectivity, ionic charge selectivity and transepithelial 
electrical resistance (TER).  The claudin family of transmembrane proteins is 
responsible for conferring these variable properties. In order to better understand the 
contribution of paracellular transport and claudins to the function of an epithelium, 
the properties conferred by cell-specific expression and localization of individual 
claudins need to be better understood.  Here, we explore the properties of claudin-
14 and the localization pattern of claudins in the liver.  Expression of human claudin-
14 significantly increases TER and decreases permeability to sodium.  Quantitative 
PCR revealed hepatic expression of 9 of 16 claudins tested at levels varying as 
much as 700-fold.  Immunofluorescent localization revealed localization of claudins-
1, -2 and -3 to hepatocytes, claudin-5 to endothelial cells, and claudins-3, -7 and -8 
to cholangiocytes.   
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CHAPTER 1.  
 
INTRODUCTION: Claudins and paracellular transport 
 
EPITHELIA:   
 The body is divided into many compartments with specialized functions.  
Epithelial cells line these compartments to create barriers and maintain 
compartmentalization.  The barrier function of epithelia is essential to proper 
physiological function, and its disruption may cause or worsen several human 
diseases including ulcerative colitis, renal disease, and deafness.   
 Epithelia are more than just barriers—they are specialized transport systems.  
The ability to selectively transport solute and water across an epithelium is critical to 
the specialized function of many epithelia and varies considerably among tissues.  
Epithelia use two types of transport systems:  the transcellular route and the 
paracellular route.  The transcellular route involves movement via membrane 
transporters and channels and may create electrical and chemical gradients 
between body compartments.  The paracellular route involves passive movement 
through the tight junction (TJ) and is influenced by the gradients developed by 
transcellular transport.  In electrical terms, the transcellular pathway can be 
represented by one pair of series resistors in parallel with the paracellular pathway 
representing another resistor (figure 1.1a).  In this way, the TJ can control the 
amount of charged solute that can move through the paracellular pathway, and as 
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we will discuss later, the TJ may also control the ionic charge and size of solute 
moving paracellularly.    
Tight Junction
Adherens
Junction
Desmosome
RA
RB
RJ
 
Figure 1.1  Schematic representations of the TJ in electrical terms (1.1a) and with 
respect to other cell-cell contacts (1.1b).  In figure 1.1a, RA is the resistance created 
by the apical membrane, RB is the resistance created by the basolateral membrane, 
and RJ is the resistance created by the tight junction (adapted from Reuss 2001).  In 
figure 1.1b, the TJ is shown in relationship to the other components of the terminal 
bar, the adherens junction and the desmosome (adapted from Schneeberger and 
Lynch 2001).   
 
 Tight Junctions:  Cell-cell contacts between epithelial cells were first 
described in 1870 using light microscopic methods.  The structure described was 
called the terminal bar, and it was assumed even at that time that its function was to 
create a barrier (Bizzozero 1870).  Nearly one hundred years later, the terminal bar 
was shown to be three distinct types of cell-cell contact: TJ, adherens junction, and 
desmosome (figure 1.1b, Farquhar and Palade 1963).  The TJ was the most apical 
of these contacts, while the desmosome was the most basal.  TJs surround the 
apical-most portion of the lateral membrane and interact with TJs on neighboring 
cells to produce a seal.  When examined under high magnification, the outer leaflet 
a. 
 
 
 
 
 
 
 
 
 
 
b. 
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of the plasma membrane at the TJ comes in such close contact with the plasma 
membrane of the adjacent cell that the membranes appear to merge.  Two opposing 
hypothesis developed to explain the structure of the tight junction:  the lipid model 
and the protein model (Schneeberger 1992).  It would be 30 years until the discovery 
of the TJ transmembrane protein occludin and acceptance of the protein model of TJ 
structure.    
 Further structural exploration of the TJ was made possible by freeze-fracture 
electron microscopy (FFEM), and these studies changed the way the TJ was 
modeled.  When visualized by FFEM, the TJ appears to be made of continuous 
fibrils.  The complexity and number of strands parallel to the apical surface varies 
widely among tissues, from 1 in mouse proximal tubule to 8 in frog urinary bladder 
(Claude and Goodenough 1973).  Claude and Goodenough (1973) found a strong 
logarithmic relationship between strand number and transepithelial electrical 
resistance (TER).  Later, Claude (1978) developed a mathematical model based on 
available morphological and physiological data available.  In this model, the TJ is 
made of pores with a certain probability of being open or closed at a given time and 
of allowing the passage of an ion.  The identification of the molecular components of 
the TJ has provided evidence that the claudin family of proteins both produces these 
variations in TER and forms these charge-lined pores.   
 Movement of solute through the TJ varies considerably in size selectivity, 
ionic charge selectivity and electrical resistance.  TER differs by several orders of 
magnitude among tissues.  For example, the TER changes considerably along the 
length of the nephron.  The proximal tubule is a leaky epithelium with a TER of 6 
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O?cm2 and permits the passage of large volumes of iso-osmotic fluid (Claude and 
Goodenough 1973).  In contrast, the distal tubule is a tight epithelium with a TER of 
300-600 O?cm2 and is able to generate and maintain electrical and chemical 
gradients.    
 In order to support the function of an epithelium, the paracellular pathway 
must also be able to discriminate based on ionic charge.  Movement through the TJ 
is passive and bidirectional.  Therefore, if a lumen negative gradient is developed by 
electrogenic transcellular transport, the charge may be dissipated by movement of 
anions from the lumen or movement of cations into the lumen.  Ionic charge 
selectivity of the TJ determines which of these occurs.  For example, a cation 
selective TJ supports the secretory function of the enteric crypts where the lumen 
negative potential is dissipated by basolateral-to-apical paracellular cation 
movement (Reviewed by Reuss 2001).  Both cation selective and anion selective 
paracellular pathways are found in the body.  In the ascending limb of the loop of 
Henle and in the enteric crypts, the paracellular pathway preferentially allows for the 
apical-to-basolateral movement of divalent cations.  In contrast, the late proximal 
tubule allows apical-to-basolateral paracellular movement of anions.   
 Molecular components of the TJ continue to be identified and now number 
near 40.  The actual cell-cell contact is formed by the transmembrane components 
which include occludin, tricellulin, junction adhesion molecule (JAM) and claudins.  
In addition to these transmembrane proteins, a large number of cytosolic scaffolding, 
signaling and polarity proteins are also associated with the TJ.   
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 A considerable body of literature now shows that the claudin family of proteins 
is the TJ component responsible for the variable properties of paracellular transport.  
Claudins have also been implicated in oncogenesis, cell polarity, and cell signaling.  
This review will focus on the contribution of claudins to transport and disease.   
CLAUDINS:  
 In 1998, the Tsukita lab identified the 22kD proteins claudins-1 and -2 from 
the junction fraction of chicken liver (Furuse 1998).   These proteins were cloned and 
expressed in MDCK cells where they localized to the TJ and to fibrils (Furuse 1998).  
Expression of claudins-1 and -2 in fibroblasts induced the formation of fibrils (Furuse 
1998).  By 1999, claudins-1 through -8 had been identified and cloned (Morita 1999).  
Currently, there are 23 mammalian claudins; some of which have one or more splice 
variants.   
 Structure:  Claudins span the membrane four times to form a cytoplasmic 
amino-terminal domain, two extracellular loops, and a cytoplasmic carboxy-terminal 
(CT) tail domain.  The first extracellular loop varies in length and, in mice, ranges 
from 43 to 56 amino acids.  This loop is characterized by a conserved W-GLW-C-C 
motif.  The conserved cysteine residues may form a disulfide bond in the oxidizing 
extracellular space and appear to be necessary for claudins to exert their 
physiological effect.  Mutations in the conserved cysteine residues of claudin-5 
abolish the positive effect of claudin-5 on TER (Morita 1999).   Charged residues in 
the first loop also influence the charge selectivity conferred by claudin expression 
(Colegio 2002).   
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 The role of the second extracellular loop is not clear.  In some claudins, it 
binds to bacterial toxin Clostridia perfringins enterotoxin (CPE), but this is not true for 
all claudins.  For example, claudins-2 and -3 bind to CPE but not claudins-1 and -4 
(Sonoda 1999).   
 The transmembrane domains appear to be important structurally.  
Palmitolyation of cysteines in transmembrane domains 2 and 4 is required for 
efficient localization of claudins (Van Itallie 2005).  Studies exchanging extracellular 
domains and carboxy-termini of claudins-2 and -4 suggest that TJ fibril architecture 
visible by FFEM and localization may be determined by the transmembrane domains 
or amino acids linking the second and third transmembrane domains (Van Itallie 
2004).   
 CT tail varies considerably in length from 25 to 114 amino acids in mouse, is 
essential for protein-protein interactions and appears to be the primary site of 
regulation.  Many of the claudins contain a conserved YV PDZ-binding motif (Itoh 
1999) in the CT tail which allows claudins to interact with PDZ-containing proteins 
like ZO-1, -2, and -3.  Obscuring or removing the last three amino acids which bind 
to PDZ domains does not block the ability of all claudins to localize to the TJ or to 
form fibrils visible by freeze fracture (Furuse 1998).  However, the strands are less 
organized, and claudins may be found on the apical membrane (McCarthy 2000).  
Not all claudins are able to associate with the TJ without a PDZ domain.  Mutations 
of the PDZ binding domain of claudin-16 abolish binding to ZO-1 and its ability to 
localize at the membrane (Ikari 2004).  In addition to PDZ-binding, the tail seems to 
be the site of phosphorylation and binding to kinases (Yamauchi 2004).  The 
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difference in PDZ-binding requirements may be related to the ability of these 
claudins to form heteromeric interaction with other claudin species or the ability to 
interact with other proteins that can direct localization.   
 Claudin CT tails also determine the half-life of a particular claudin (Van Itallie 
2004).  Association with PDZ-containing proteins does not affect half-life, which 
suggests involvement of other protein-protein interactions in controlling half-life (Van 
Itallie 2004).  Because of the differences in claudin half-life for different claudin 
species, these studies also suggest the different claudin tails participate in different 
protein-protein interactions.   
 Much about how claudins in the same cell and adjacent cells interact remains 
unknown.  Biochemical analysis of claudin-4 shows formation of hexamers (Mitic 
2003).  This study was supported by Coyne, et al (2003) who show that claudin-5 
forms hexameric complexes in human airway epithelia.  Recent FRET studies 
confirm that claudins interact homotypically (Blasig 2006).  However, this study also 
reports that claudin-5 forms homodimers rather than hexamers.  While these studies 
appear to be in opposition, both may be true—claudins may form complexes as 
trimers of dimers.  Claudin-claudin interactions have also been observed between 
different claudins, although not all claudins appear to interact.  For example, claudin-
3 will co-immunoprecipitate with claudins-1 and -5, but claudins -1 and -5 will not co-
immunoprecipitate (Coyne 2003).   
 The nearly 25 claudin family members show complex patterns of expression, 
which may account for the variable paracellular transport properties in different 
epithelia.  Several groups have profiled claudin expression in the kidney, the liver, 
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the gastrointestinal tract, and the inner ear (Reyes 2002, Kiuchi-Saishin 2002, Li 
2004, Rahner 2001, Holmes 2006, Kitajiri 2004, Florian 2003).  These groups have 
documented complex patterns of expression which vary within tissues and during 
development.  Based on studies of exogenous claudins in cultured monolayers, we 
are beginning to understand the electrical properties of individual claudins (as 
discussed below).  This emerging information, coupled with tissue surveys showing 
the distributions of the individual claudins, will allow us to define the physiological 
role of claudins in transepithelial transport.     
 Claudins and electrical properties:  Claudins contribute to the differences in 
electrical properties of epithelia.  Cell culture models have begun to reveal the 
electrical properties of individual claudins.  These data are difficult to apply directly to 
understanding the contribution of these claudins to tissues because this data is 
derived from gross overexpression in relation to the low endogenous levels of 
claudins in tissues.  However, in some cases, the electrophysiological data fit well 
with predictions based on the expression patterns of claudins.  Claudin-2, for 
example, is expressed in the leaky proximal tubule and decreases TER when 
expressed in MDCK and LLC-PK1 cells, while claudins-7 and -8 are confined to the 
high resistance distal nephron segments and increase TER in cultured cell lines 
(Enck 2001, Furuse 2001, Van Itallie 2003, Alexandre 2005, Yu 2003).    
 Exogenous expression of claudins also confers certain charge-selective 
properties on an epithelial monolayer.  Many claudins either increase or decrease 
permeability to sodium, while claudin-7 alone seems to influence chloride 
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permeability (Alexandre 2005).  The charged residues on the first extracellular loop 
provide the basis for these differences in permeability.   
 The first extracellular loop varies from one claudin to another in the number of 
charged residues.  Colegio, et al (2002) showed that reversing the charges on the 
first loop of claudin-15 reversed the charge selectivity when expression was induced 
in MDCK cells.  Similar results were seen in a mutational analysis of claudin-16 (Hou 
2005).  There is also a strong correlation between the number of charges in loop one 
and the charge selectivity (Van Itallie 2003).  Together, these data support the 
concept that claudins form charge-lined pores to filter the passage of ions and that 
the first extracellular loop forms these pores.   
 Claudins and size selectivity:  In order to understand the TJ structurally, it is 
critical to know its pore size and whether the pore size changes in physiological and 
pathological states. To resolve the pore size, paracellular movement of non-charged 
tracers of known sizes is measured.  As the size of the tracer increases, the 
paracellular permeability decreases; the tracer size at which permeability becomes 
zero is defined as the pore size.  Polyethylene glycol (PEG) oligomers of different 
sizes may be used for this purpose.  In the model presented by Watson, et al (2001), 
mathematical modeling of the paracellular pore reveals differences in pore size, 
number of size restrictive pores, and the number of unrestrictive pores.  Using PEG 
oligomers, the radius of the restrictive pores was defined as 4.5 Å in Caco-2 cells 
and 4.3 Å in T84 cells (Watson 2001).  Unrestrictive pores are not holes in the 
membrane, but are pores that allow passage of molecules greater than 4.5 Å and 
have a greater probability of being closed under normal conditions.  The size 
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restrictive pore is the dominant pore in normal culture conditions allowing greater 
than 20-fold more solute to pass through the paracellular pathway than the size 
unrestrictive pore.  Using this model, interferon-? (IFN?) was shown to modulate the 
number of unrestrictive pores (Watson 2005).  The authors suggest that during acute 
inflammation increasing the number of unrestrictive pores will allow the paracellular 
movement of antigens without disturbing the movement of small molecules.  A role 
for the TJ transmembrane components is suggested by the redistribution of claudin-
1 and occludin between soluble cytosolic and insoluble junctional pools with 
treatment (Watson 2005).   
 The most direct evidence for a link between claudin and pore size stem from 
the phenotype of the claudin-5 knockout (KO) mice.  Shortly after the discovery of 
claudins, claudin-5 was found to localize to the TJ of endothelial cells (Morita 1999).  
Mice with claudin-5 deficiencies died 10 hours after birth due to abnormalities in the 
blood-brain-barrier despite the presence of other claudins, including claudin-12 (Nitta 
2003).  The morphology of the blood vessels and the TJ were not noticeably altered 
in the claudin-5 KO mice.  The authors suggest that claudin-5 creates smaller pores 
than the other claudins expressed at the blood brain barrier.  Interestingly, in mice, 
the pore-forming first extracellular loop of claudin-5 is 8 amino acids shorter than 
that of claudin-12. 
 Mouse Models of Claudin Function:  Several mouse models have 
demonstrated that claudins are critical for barrier function, and as noted above, the 
claudin-5 KO suggests a role for claudins in defining size selectivity of the TJ pore 
(table 1.1).   
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Claudin Phenotype Reference 
Claudin-1 KO Epithelial barrier defect Furuse 2002 
Claudin-5 KO Blood-brain-barrier defect Morita 1999 
Claudin-6 Tg Epithelial barrier defect Turksen 2002 
Claudin-11 KO CNS defect/ deafness Gow 1999, Kitajiri 2004, Gow 2004 
Claudin-14 KO Deafness Ben-Yosef 2003 
Claudin-19 PNS defect Miyamoto 2005 
Table 1.1  Summary of phenotypes associated with claudin null or transgenic (Tg) 
mice.    
 
 Two claudins have been implicated in epidermal barrier function, claudins-1 
and -6.  Claudin-1 KO mice die shortly after birth due to defects in epithelial barrier 
(Furuse 2002).  This study showed, surprisingly, that claudins influence the barrier 
function of the epidermis, a stratified epithelia, as well as simple epithelia.  The 
impact of claudins on barrier function of stratified epithelia was confirmed in claudin-
6 transgenic mice.  When claudin-6 is expressed under the control of the skin-
specific Inv promoter, mice homozygous for this transgene die shortly after birth due 
to epithelial barrier defects (Turksen 2002).  A direct role for claudin-6 is difficult to 
verify due to alterations in the expression level of other claudins.  Studying mice 
heterozygous for the transgene revealed defects in differentiation of the skin and 
suggests a role for claudins in directing differentiation (Troy 2005).   
 The unique compartment of the inner ear appears to be maintained in part by 
claudins.  The hair cells of the inner ear are bathed in a potassium rich endolymph.  
The endolymph has an abnormally high K+ concentration (150 mM) and a positive 
endocochlear potential (+80 mV).  Claudin-11 KO mice are deaf due to 
endocochlear potential loss with no changes in K+ levels (Kitajiri 2004, Gow 2004).  
These data suggest that the basal cell layer is responsible for maintenance of the 
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endocochlear potential, and the authors purport that the marginal cell layer is 
responsible for maintenance of the potassium gradient.  This hypothesis is 
supported at least in part by the claudin-14 KO mice.  Claudin-14 is expressed in the 
marginal cell layer, and claudin-14 KO mice initially are able to generate an 
endocochlear potential (Ben Yosef 2003).  However, the potassium levels in the 
endolymph were not measured, and interpretation of these results are complicated 
by the degeneration of hair cells.   
 Myelin sheaths created by glial cells of the central and peripheral nervous 
systems (CNS and PNS) have TJ-like structures.   Before the claudin family was 
described, claudin-11 was known as oligodendrocyte specific protein because it was 
expressed by oligodendrocytes, the glial cells of the brain.  Claudin-11 KO mice lose 
TJs within the layers of myelin and have decreased CNS conduction velocities (Gow 
1999).  Claudin-19 is expressed by Schwann cells, the glial cells of the PNS, and 
seems to be the PNS counterpart of claudin-11.  Claudin-19 KO mice lose TJs and 
have decreased PNS conduction velocity (Miyamoto 2005).    The glial cells of the 
nervous system create several specialized compartments to facilitate saltatory 
conduction of action potentials, and these studies suggest that claudins are essential 
to this process in both the CNS and PNS.   
  Claudins and Disease:  Several human pathologies have been linked to 
claudins and paracellular transport (table 1.2).  Genetic mutations in claudins-1, -14 
and -16 cause three very different pathologies, affect four different tissues and 
demonstrate the importance of regulation of the paracellular transport pathway.   
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 Neonatal sclerosing cholangitis with ichthyosis is associated with mutations in 
claudin-1 which cause a frameshift mutation leading to a premature translation stop 
(Hadj-Rabia 2004).  Patients with this disease show varying degrees of sclerosis and 
inflammation of their bile ducts and scaling skin and lack claudin-1 expression in 
both their livers and cultured skin fibroblasts.  Despite the fact that the four patients 
studied bore the same mutation, the manifestation and progression of the disease 
differed considerably.  One patient even exhibited complete regression of cholestatic 
symptoms.  When the phenotype of the claudin-1 KO mice was described, the 
associated ichthyosis of the human disease prompted the investigators to search for 
a mutation in claudin-1.  The early lethality of these mice likely explains why there is 
no reported liver dysfunction, as seen in humans.  Closer examination of these mice 
or development of a tissue-specific knockout may reveal the role of claudin-1 in liver 
and may provide some clues as to how this disease develops and progresses.   
Claudin Disease Reference 
Claudin-1  Neonatal sclerosing cholangitis with ichthyosis Habj-Rabia 2004 
Claudin-14 Deafness DFNB29 Wilcox 2001 
Claudin-16 Familial hypomagnesaemia with hypercalciuria 
and nephrocalcinosis 
Simon 1999 
Table 1.2  Summary of human diseases associated with mutations in claudins.   
  
Claudin-14 is mutated in the autosomal recessive, nonsyndromic deafness DFNB29 
(Wilcox 2001).  In a small population in Pakistan, two mutations were identified: a 
frameshift mutation leading to a premature stop and an amino acid substitution of 
aspartic acid for valine in transmembrane domain two.  Another study of Greek and 
Spanish cohorts revealed an amino acid substitution of arginine for glycine also in 
transmembrane domain two (Wattenhofer 2005).  The introduction of a charged 
residue in a transmembrane domain impaired export of the mutant proteins to the 
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plasma membrane when expressed in fibroblasts (Wattenhofer 2005).  In humans as 
in mice, claudin-14 appears to be critical for maintenance of the electrical gradient, 
the potassium gradient, or both.   
 The first claudin linked to a genetic disorder was claudin-16, which causes 
familial hypomagnesaemia with hypercalciuria and nephrocalcinosis (FHHN) when 
mutated.  Simon, et al (1999) identified two mutations in claudin-16: a premature 
stop and a substitution of arginine for glycine in transmembrane domain four.  
Following the identification of these mutations, claudin-16 was found to localize to 
the thick ascending limb of the loop of Henle (TAL), the nephron segment 
responsible for reclaiming most of the Mg2+ filtered through the glomerulus.  This led 
to the hypothesis that claudin-16 selectively enhances the reabsorption of the 
divalent cations Mg2+ and Ca2+.  Expression of claudin-16 has revealed that its 
expression enhances paracellular transport of divalent cations (Ikari 2004, Hou 
2005).  Permeability to Na+ increases even more dramatically than permeability to 
Mg2+ when claudin-16 is expressed in LLC-PK1 cells (4-fold versus 1.6-fold, Hou 
2005).  This was not entirely surprising since claudins do not appear to discriminate 
between ionic species of the same charge.  Because reabsorption of Mg2+ is 
dependent upon the lumen positive electrical potential in the TAL and claudin-16 
shows high permeability to cations, Hou, et al (2005) suggest a model where 
claudin-16 helps maintain the lumen positive potential by allowing backflow of Na+, 
which facilitates Mg2+ reabsorption.  The role of claudin-16 may be a balance 
between allowing Mg2+ reabsorption and Na+ backflow which will both allow Mg2+ 
transport and maintain its driving force.  Claudin-11 and its role in maintaining the 
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endocochlear potential provide a precedent for the participation of claudins in the 
generation or maintenance of potential across an epithelium, and the major function 
of claudin-16 may be maintaining the lumen positive potential of the TAL.  A similar 
renal disease associated with claudin-16 mutations has also been identified in cows 
(Hirano 2000).   
 Non-barrier function of claudins:  A considerable literature has emerged 
showing that claudin expression is altered in a variety of cancers.  A causal 
relationship has not been established; however, recent data suggest that claudin-1 
may have a role in transformation, growth and metastasis of colon cancer (Dhawan 
2005).  Claudin-1 is upregulated in colon carcinomas and metastatic lesions and is 
relocalized from the TJ to the lateral surface, cytoplasm and nucleus.  Claudin-1 
RNA interference in colon cancer cell lines leads to decreases in invasion, 
tumorigenesis, and ß-catenin/Tcf/Lef signaling.  Although it is still unclear what the 
primary disturbance is and whether APC is acting in a ß-catenin independent 
fashion, this data provides the first evidence that claudins may impact on the 
progression of cancer.   
CLAUDINS AND REGULATION OF THE PARACELLULAR PATHWAY  
 The properties of the paracellular transport pathway are altered in a variety of 
conditions, including total parenteral nutrition, colon cancer, Crohn’s disease, 
ulcerative colitis, cytokine exposure, Na+/K+ ATPase inhibition, and other inputs that 
alter cell signaling (Kansagra 2003, Gitter 2001, Olaison 1998, Soderholm 2002, 
Russo, 2003, Rjasekaran 2004, Madara 1994).  Regulation of claudins may account 
 16 
for transport differences under these conditions and may be involved in 
differentiation, growth, and inflammation.       
 Transcriptional regulation of claudin expression:  Transcription factors 
involved in regulating claudin expression are often associated with either 
differentiation, where expression of specific claudins is turned on, or 
dedifferentiation, where claudin expression is turned off (figure 1.2).  The epithelial 
cells of the intestine undergo continuous differentiation along the crypt-to-villus axis, 
and claudins are differentially expressed along the axis and during development 
(Holmes 2006).  The transcription factors responsible for regulating claudin 
expression are beginning to be uncovered.  GATA-4, CDX2, and HNF1a activate the 
claudin-2 promoter in a cooperative fashion in colon (Escaffit 2005).  Lef/Tcf of the 
Wnt signaling pathway also enhances claudin-2 expression (Mankertz 2004).  
Transcription factors involved in differentiation of epithelial cells in other tissues 
regulate claudin expression, including HNF4a, RXRa, and RAR? which induce 
expression of claudins-6 and -7 (Satohisa 2005, Kubata 2001).   
 The epithelial-mesenchymal transition (EMT) occurs during development and 
is necessary for mesoderm and neural crest formation.  EMT involves loss of cell-
cell adhesion and increased cell motility and may take on a pathological form in 
tumor invasion.  In the process of adhesion loss, expression of adherens junction 
and TJ components is decreased.  Snail is a transcription factor involved in this 
process.  Claudins-3, -4, and -7 contain binding sites for snail in their promoters, and 
snail down-regulates expression of these claudins in Eph4 cells (Ikenouchi 2003).  
When snail expression is induced at low levels in MDCK cells, ionic permeability is 
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increased, and claudins -1, -2, -4, and -7 are down regulated (Martinez-Estrada 
2006, Carrozzino 2005).   
 Other transcription factors also mediate the tissue-specific expression of 
several claudins.  For example, the lung, brain and thyroid specific transcription 
factor T/EBP/NKX2.1 regulates a lung-specific form of claudin-18 (Niimi 2001).  
Peroxisome proliferator-response element in the promoter of claudin-16 appears to 
play a role in the cell-specific expression of claudin-16.  The transcription factors and 
response elements responsible for cell-specific expression of other claudins remains 
to be determined.    
 
Figure 1.2  Transcription factors influencing claudin expression involved in 
differentiation and dedifferentiation.  Claudin expression is positively regulated by 
GATA4/CDX2/HNF1a (Escaffit 2005), RXRa/RAR? (Kubata 2001), HNF4a (Satohisa 
2005) and Cdx1/Cdx2/HNF1a (Sakaguchi 2002) to enhance barrier function.  
Claudin expression is negatively regulated by snail (Ikenouchi 2003, Martinez-
Estrada 2006, Carrozzino 2005) to decrease differentiation and barrier function.    
 
 Phosphorylation of claudins:  Transport properties of epithelia, especially in 
the kidney, are regulated acutely by a number of mechanisms, and phosphorylation 
GATA4/CDX2/HNF1a 
RXRa/RAR? 
HNF4a 
Cdx1/Cdx2/HNF1a 
Snail 
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of claudins may be targets for such regulation.  The most compelling example of this 
is regulation of NaCl transport in the distal nephron by WNK4.  WNK4 is a kinase 
mutated in some forms of pseudohypoaldosteronism type II (Yamauchi 2004).  This 
disease is characterized by increased paracellular Cl- permeability which leads to 
hypertension and hyperkalemia.  Claudins were investigated as a target of this 
kinase.  Expression of the human mutant WNK4 in MDCK cells leads to an increase 
in paracellular Cl- permeability.  This mutant does not cause gross structural 
changes to the TJ but does induce phosphorylation of claudins-1 through -4 (Kahle 
2004, Yamauchi 2004).  In other culture studies of claudin phosphorylation, the 
physiological effect of claudin-1 and -3 phosphorylation is subtle (Fujibe 2004, 
D’Souza 2005), but it is also possible that the claudins now known to be 
phosphorylated by WNK4 are not the only or primary targets.  Claudin-7, for 
example, has a greater effect on Cl- permeability than other claudins and, like 
WNK4, is expressed in the distal nephron (Alexandre 2005).  Further investigation 
may reveal one of two things:  claudin-7 or other anion-selective claudins are a 
major target for phosphorylation, and phosphorylation increases its influence on 
paracellular transport; or that cation selective claudins are the major targets, and 
phosphorylation decreases their ability to control paracellular transport.    In addition 
to regulation of claudins through WNK4, aldosterone signaling may affect claudin 
phosphorylation and physiological activity.  Aldosterone treatment of the collecting 
duct-derived cell line RCCD2 causes an increase in Cl- permeability without 
changing Na+ permeability and induces rapid and transient phosphorylation of 
claudin-4 on threonine residues (Le Moellic 2005).   
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 Claudin phosphorylation may either increase or decrease paracellular 
permeability.  For example, phosphorylation of claudin-1 seems to decrease 
permeability, while phosphorylation of claudins-3 and -5 seems to increase 
permeability (Fujibe 2004, D’Souza 2005, Ishizaki 2003, Soma 2004).  The 
mechanism of action remains unclear, but some studies of claudin solubility suggest 
that association with the TJ may be altered by phosphorylation (Fujibe 2004, Banan 
2005).    
 Endocytosis of claudins:  In acute regulation of the TJ, claudins may undergo 
endocytosis in response to activation of signaling pathways and regulation of 
phosphorylation.  Live cell imaging has revealed co-endocytosis of apposing strands 
(Matsuda 2004).  IFN? has been shown to induce barrier loss and endocytosis of 
claudin-1 and other TJ components through activation of Rho-associated kinase and 
myosin II, which confirms that endocytosis is a mechanism for regulation of the TJ 
and also has implications for irritable bowel disease (IBD) (Utech 2005).  
 Regulation of claudins by cytokines and growth factors:  There is 
considerable evidence for regulation of claudins by growth factors and cytokines.  Of 
particular importance is regulation by inflammatory cytokines associated with 
disease, especially diseases like IBD and ulcerative colitis (Walsh 2000).  It has long 
been known that cytokines and growth factors can modulate the permeability of an 
epithelial monolayer, and considerable evidence now suggests that claudins are 
targets of this regulation (figure 1.3).  The influence of cytokines and growth factors 
on claudins may involve regulation by transcription, phosphorylation, and 
endocytosis.  The mechanisms for this regulation are largely unknown, but there is 
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strong evidence that ERK has a role in altering claudin expression and paracellular 
permeability in response to a number of growth factors (Kinugasa 2000, Howe 2005, 
Lipschutz 2005).   
 
 
Figure 1.3  Cytokines and growth factors that either increase or decrease 
paracellular permeability (adapted from Walsh 2000).  EGF (Singh 2004), TGFß 
(Howe 2005), IL-15 (Nishiyama 2001) and IL-17 (Kinugasa 2000) decrease 
paracellular permeability by creating a tighter junction.  IL-13 (Heller 2005), TNFa 
(Poritz 2004), IL-1ß (Yamamoto 2004), HGF (Lipschutz 2005) and IFN? (Willemsen 
2005, Tedelind 2003, Watson 2005) increase paracellular permeability by creating a 
leakier junction.   
  
Treatment of MDCK cells with EGF leads to a decrease in claudin-2 expression and 
an increase in claudin-1, -3 and -4 expression (Singh 2004).  This leads to a 
significant rise in TER.  Pharmacological inhibition of ERK activation completely 
blocks this effect of EGF.  Likewise, ERK activation by constitutively active MEK 
facilitates the decrease in claudin-2 expression and increase in TER induced by 
treatment with hepatocyte growth factor or by overexpression of ERK (Lipschutz 
Decreased Permeability: 
EGF, TGFß,  
IL-15 via IL-2Rß, IL-17 
Increased Permeability:  
IL-13, TNFa, IL-1ß,  
HGF, IFN? 
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2005).   Inhibition of ERK in cell lines that show high basal activation of ERK 
increases the expression of claudin-2 and decreases TER (Lipschutz 2005).  TGF-
ß1 treatment acts via the ERK pathway to decrease claudin-1 and -2 expression, 
cause barrier loss and promote EMT (Medici 2006).    
CONCLUSION:   
 The charge-lined pores created by claudins dynamically control paracellular 
transport in epithelial tissues, but the signals and mechanisms responsible for the 
dynamic nature are only beginning to be uncovered.  To help us appreciate the 
contribution of the paracellular pathway and of individual claudins, we need to 
understand what characteristics the claudins have and where they are expressed.  
This will allow us to explore the role of claudins in normal physiology and 
pathophysiology and the possibility of using claudins as therapeutic targets.  In the 
remainder of this thesis, I will describe the electrophysiological characteristics of 
claudin-14 and the expression pattern of claudins in mouse liver.  
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CHAPTER 2.   
 
Electrophysiological characterization of claudin-14 reveals its unique  
cation-restrictive, high resistance properties 
 
INTRODUCTION:  
 The scala media of the inner ear is a highly specialized compartment filled 
with endolymph, a unique fluid with 150 mM K+ and an endocochlear potential of +80 
mV.  Hair cells of the inner ear convert the mechanical stimulus created by sound 
waves into an electrical stimulus that is sent to the central nervous system.  Sound 
waves lead to mechanical deformation of the hair cell stereocillia, which causes 
opening of mechanically gated K+ channels and depolarization of the hair cells 
(figure 2.1a).  Depolarization the hair cell leads to release of stimulatory 
neurotransmitters.    
 The chemical and electrical composition of the endolymph is necessary for 
hearing and must be created and maintained by the epithelia lining the inner ear.  In 
order for depolarization to occur, the chemical and electrical gradients across the 
apical membrane of the hair cell must be maintained.  For the hair cells to repolarize, 
the K+ gradient across the basolateral membrane must be maintained so that K+ 
may be cycled out of the hair cell and eventually back into the endolymph.   
 Epithelia form physical barriers to maintain compartmentalization.  They also 
have transport systems in place to allow selective transport from one compartment 
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to another.  Transcellular transport involves movement through the cell and may 
generate electrical and chemical gradients, while paracellular transport is passive 
movement of solute through the tight junction (TJ).  Like the transcellular pathway, 
the paracellular pathway differs in tissues.  The properties of transepithelial electrical 
resistance (TER), ionic charge selectivity, and size selectivity vary considerably  
 
Figure 2.1 Schematic representation of the claudin-14 within the inner ear and the 
general structure and sequence of claudin-14.  Figure 2.1a demonstrates 
mechanotransduction in the inner ear (adapted from Boron and Boulpaep).  Figure 
2.1b shows a schematic representation of a claudin molecule.  Here the charged 
residues of claudin-14 are shown on loop one (blue=positive and red=negative).  
The specific sequence of claudin-14’s first extracellular loop is shown in figure 2.1c.   
 
between tissues.  The claudin family of TJ proteins is now known to control the 
variable properties of paracellular transport.  The claudins are integral membrane 
proteins that span the membrane 4 times and create 2 extracellular loops (figure 
2.1b).  When expressed in cultured cells, different claudins confer different electrical 
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properties.  The charged residues on loop 1 are responsible for conferring the 
property of charge selectivity (Colegio 2002).  There is a strong correlation between 
the charge preference and the net charge of loop 1 (Van Itallie 2003).   
 In the inner ear, claudins-11 and -14 help maintain the electrical and chemical 
composition of the endolymph by influencing the barrier properties of the inner ear.  
Claudin-11 knockout (KO) mice lose the positive endocochlear potential and are 
deaf (Kitajiri 2004, Gow 2004).  Potassium levels in these mice are maintained, 
which suggests that claudin-11 is more involved in maintenance of the electrical 
gradient than the chemical gradient of the inner ear.  Claudin-14 is mutated in a rare 
non-syndromic deafness DFNB29 (Wilcox 2001).  Claudin-14 KO mice are able to 
generate an endocochlear potential initially, but the hair cells degenerate, leading to 
deafness (Ben-Yosef 2003).  Because of the deafness associated with mutations in 
claudin-14 and the net charge of loop 1 is +3, we hypothesize that expression of 
claudin-14 limits the passage of cations to help maintain the K+ concentration in the 
endolymph (figure 2.1c).  To test this hypothesis, we cloned claudin-14, expressed it 
in MDCK cells, and tested the electrical properties of charge selectivity and TER.  
The elevation of TER and restriction of cations found in MDCK cells expressing 
claudin-14 supports the hypothesis that claudin-14 limits the paracellular passage of 
K+ to maintain the K+ concentration endolymph.   
MATERIALS AND METHODS:   
 Cloning of human claudin-14:  Claudin-14 was cloned from a human kidney 
cDNA library using standard PCR techniques, cloned into the TOPO TA vector 
(Invitrogen Corp.) and transferred into the pTRE vector so that gene expression may 
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be induced by the absence of tetracycline or doxycycline (Clonetech Laboratories 
Inc.).  An inducible expression system was chosen to control for clonal variability.  
Correct sequence was verified with DNA sequencing.   
 Generation of clones stably expressing claudin-14:  Claudin-14 was co-
transfected with a zeocin resistance vector into the doxycycline repressible tet-off 
MDCK cells (Clonetech Laboratories Inc.) using lipofectamine (Invitrogen Corp).  
Clones were selected for in zeocin-resistance.  Inducible expression was confirmed 
using standard immunoblot and immunofluorescence techniques with an antibody 
raised against human claudin-14 (Zymed).  Claudin-14 was tightly inducible and 
expressed in all cells.     
 Cell Culture:  For experiments, cells were trypsinized and plated on snapwell 
filters at a density of 5x104 cells per well.  Cells were maintained in medium (High 
glucose DMEM with penicillin/streptomycin and 10% Tet-free FBS) with or without 
doxycycline (50ng/mL).  The culture medium was changed daily.   
 Immunoblot:  The filters on which cells were grown were removed and placed 
in 200 µL of 4x SDS-sample buffer.  Samples were stored at -80oC before analysis.  
Equal volumes of uninduced and induced lysate from each clonal line were 
subjected to SDS-PAGE (4-12% polyacrylamide gels) and transferred to 
nitrocellulose.  The nitrocellulose was probed simultaneously with a rabbit polyclonal 
antibody raised against human claudin-14, a rabbit polyclonal antibody raised 
against ß-tubulin, and a rat monoclonal antibody raised against ZO-1.  A secondary 
antibody conjugated to HRP was used to detect antigen-antibody complexes by 
enhanced chemiluminescence (ECL) reagents (Amersham Pharmacia Biotech Inc).   
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 Electrophysiology:  Electrophysiological measurements were conducted 
according to the methods in Van Itallie, et al (2001) on cells grown on filters in 
modified Ussing chambers (Harvard Apparatus Co.) with a microcomputer controlled 
voltage/current clamp (Harvard apparatus Co.) and Ag/AgCl electrodes with 
microporous ceramic tips.  Temperature was maintained at 37oC.     
 At the beginning of each experiment, fluid resistance and electrode potentials 
across blank filters were measured in buffer A (120 mM NaCl, 10 mM HEPES, pH 
7.4, 5 mM KCl, 10 mM NaHCO3, 1.2 mM CaCl2, 1 mM MgSO4, 37oC) and subtracted 
from all subsequent measurements.  Dilution potential, or paracellular ionic 
preference in the presence of a concentration gradient, was also measured for blank 
filters with buffer B (60 mM NaCl, 120 mM Mannitol, 10 mM HEPES, pH 7.4, 5 mM 
KCl, 10 mM NaHCO3, 1.2 mM CaCl2, 1 mM MgSO4, 37oC) in either the apical or 
basolateral chamber and buffer A in the other chamber.  The dilution potential 
measured for the blank filter was subtracted from dilution potentials measured for 
uninduced or induced MDCK cells.   
 The blank filters were removed from the Ussing chamber and replaced with 
filters containing confluent monolayers of either uninduced or induced cells.  To 
remove residual media, the cells were washed twice on both sides with buffer A 
before electrophysiological measurements.  TER was measured by voltage 
deflection when the monolayer was subjected to 40 µA current pulses.  Stability of 
conductance and transmonolayer potential measurements were confirmed by 
repeated measurements for at least one minute.  The apical buffer was then 
aspirated, replaced by buffer B, aspirated, and replaced again with buffer B.  
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Measurement of conductance and transmonolayer potential was performed 
immediately, and stability was verified by continuing to take measurements for one 
minute.  Filters were then removed and placed in sample buffer for immunoblot 
analysis.   
 To calculate the absolute permeability to Na+ (x) and Cl- (y), the following 
equation and the Goldman-Hodgkin-Katz constant-field assumptions were used:   
 ?? = RT/F [ln(aox+ßaiy)/aix+ßaoy)] 
where ?? = measured potential difference (dilution potential), R=  universal gas 
constant, T= absolute temperature, F= the Faraday constant, ax= activity of cation x, 
ay= activity of anion y, and ß= permeability ratio, Py/Px (Goldman 1943, Hodgkin and 
Katz 1949).  Once the relative permeability (ß) of the monolayer is calculated, the 
TER and intracellular and extracellular concentrations of cation x and anion y are 
used to calculate the absolute permeability of the TJ the respective anions (Van 
Itallie 2001).    
RESULTS:   
 MDCK cells do not endogenously express claudin-14 by immunoblot or 
immunofluorescence (figure 2.2a and data not shown).  Removal of doxycycline 
from the cell culture media for 4 days allowed successful induction of claudin-14 
expression and localization of claudin-14 to the TJ (figure 2.2a and data not shown).  
Expression of claudin-14 in MDCK cells brought about a 6-fold increase in TER 
(figure 2.2b).  The dilution potential is also reversed from cation selective to cation 
restrictive (figure 2.2c), which occurs because the permeability to Na+ decreases 
(figure 2.2d).  Claudin-14 expression has no effect on Cl- permeability (figure 2.2d).   
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Figure 2.2 Induction of claudin-14 expression in cultured epithelial monolayers 
increases resistance and decreases cation permeability.  Figure 2.2a shows 
successful induction of claudin-14 by immunoblot.  (b) Claudin-14 expression 
induces a significant increase in TER from 52.7±2.6 Oxcm2 to 293.0±34.8 Oxcm2.   
(c) Dilution potential decreases significantly from 7.28±0.47 mV to -2.42±0.26 mV 
due to a shift in Na+ and Cl- permeability (PNa and PCl).  (d) PNa significantly 
decreases from 28.03±1.11 10-6 cm/sec to 7.7±0.76 10-6 cm/sec with claudin-14 
induction, while PCl does not change (10.37±0.51 10-6 cm/sec to 10.7±1.45 10-6 cm/sec).  
*P<0.001.   
 
DISCUSSION:   
 Electrophysiological characterization of claudin-14 in MDCK cells reveals a 
unique claudin with high resistance and the ability to limit paracellular cation 
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transport.  The ability to limit cation transport is not unsurprising since the net charge 
of the residues of claudin-14’s first loop is +3.  The increase in TER coupled with the 
changes in cation but not anion transport is similar to that seen for claudin-4, but the 
magnitude of change is much greater for claudin-14 (Van Itallie 2001).  Indeed, the 
magnitude of increase in TER is higher than that of any claudin characterized to date 
(Van Itallie and Anderson 2006).    
 We hypothesized that claudin-14 acts to limit the paracellular movement of 
cations in the inner ear, and the electrophysiological properties measured for 
claudin-14 fit well with a model where claudin-14 contributes to maintaining the 
composition of the endolymph by limiting the paracellular movement of cations.  We 
chose not to measure K+ because claudins do not seem to discriminate well 
between ions of the same charge.  However, measuring the potassium potential of 
claudin-14 KO mice and comparing it to wildtype mice would provide the best 
verification of this hypothesis—this  experiment has not been done.  In the KO mice, 
normal TJ fibril architecture is seen, so presumably the barrier is still largely intact 
but lacking a claudin with the appropriate charge discriminatory characteristics (Ben-
Yosef 2003).   
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Chapter 3.   
 
Characterization of claudin expression and localization in the liver 
 
INTRODUCTION:   
 Bile acid-containing blood enters the liver through the portal vein, flows 
through the sinusoids over a row of specialized epithelial cells called hepatocytes 
and leaves via the central vein.  The liver hepatocytes reclaim bile acids from the 
blood and secrete them into bile for storage in the gallbladder and release into the 
duodenum where it aids in fat solubilization and digestion (reviewed in Trauner 
2002).  The hepatocytes near the portal vein are called periportal, and the 
hepatocytes near the central vein are called pericentral.   
 Hepatocytes transport bile acids up a 100- to 1000-fold concentration gradient 
from blood into the cannaliculus (Boron and Boulpaep 2004).  The bile then flows 
through the cannaliculus into the bile ductules and ducts where it may be further 
modified by the billiary epithelium made of cholangiocytes.  By the time, bile reaches 
the gallbladder, it may have been concentrated up to 10-fold compared to the 
cannalicular bile (Nathanson 1991).   
 Secretion of bile acids into the cannaliculus is driven by the active transport of 
bile acids followed by passive movement of water, ions, and other solute (Boyer 
2002).  The periportal hepatocytes are primarily responsible for reclaiming bile acids, 
although the pericentral may transport bile acids as an adaptation (Jones 1980, 
Groothuis 1982).  Bile acid transporters and aquaporins show either a gradient of 
 
 41 
activity or expression with bile acid transporting activity concentrated at the 
periportal hepatocytes (Huebert 2002, Reichel 1999, Kakyo 1999, Konig 1999, 
Scheffer 2002).   
 Transport in the bile ducts by cholangiocytes may alter the electrolyte content 
of bile or may remove bile acids from the bile.  The cholangiocytes exchange HCO3- 
for Cl- and express the cystic fibrosis transmembrane regulator (CFTR) chloride 
channels, which may account for the cholestatic liver disease associated with 
mutations in CFTR (Oppenheimer 1975).   The removal of bile acids occurs at very 
low rates and is hypothesized to be involved in signaling since bile acids may 
activate a number of signaling molecules and transcription factors.   
 The contributions of active and secondary active transport to reclaiming and 
processing bile are beginning to be understood based on human genetic disorders 
and mouse models, but the contribution of the tight junction (TJ) and paracellular 
transport is not yet appreciated.  At least two human liver diseases are associated 
with mutations in TJ components:  ZO-2 and claudin-1 (Carlton 2003, Habj-Rabia 
2004).  Mutations in the first PDZ domain of ZO-2 are co-inherited with mutations in 
bile acid Coenzyme A: amino acid N-acyl-transferase (BAAT) in a familial 
hypercholanemia, characterized by elevated serum bile acids and fat malabsorption 
(Carlton 2003).  Claudin-1 is mutated in neonatal sclerosing cholangitis with 
associated ichthyosis (Hadj-Rabia 2004).   
 The paracellular transport system involves passive movement of solute down 
a chemical or electrical gradient through the TJ and seems to be directed by the 
claudin family of transmembrane proteins.  The 25 members of the claudin family 
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are differentially expressed in tissues and confer variable properties of ionic charge 
selectivity and resistance.  The complex distribution of the claudin family is clear 
from studies characterizing expression in the gastrointestinal tract, kidney, and inner 
ear, but the implications and significance of these patterns are little understood.  As 
a first step in understanding the contribution of claudins to transport in the liver, this 
study assayed the relative expression of claudins using quantitative PCR and their 
localization using immunohistochemistry.   
MATERIALS AND METHODS:   
 Mouse handling and tissue collection:  All animal handling and tissue 
collection was performed in accordance with the Institutional Animal Care and Use 
Committee of the University of North Carolina at Chapel Hill.  Livers were collected 
on ice from 6-week old, male C57/Black 6 mice.  Samples were collected for RNA 
analysis and immunohistochemistry.   
 Liver tissue samples for RNA analysis were collected and stabilized in 
RNAlater, an RNA stabilizing solution (Ambion, Inc.).  These samples were stored at 
4oC for 24 hours to allow RNALater to fully penetrate the sample and then stored 
long-term at -80oC.  RNA was collected from these tissues using the RNeasy kit 
(Quiagen, Inc.) according to manufacturer’s instructions following homogenization 
with the tissuelyzer (Quiagen Inc.).  DNA contamination was removed from the RNA 
using TURBO DNase (TURBO DNA-free kit, Ambion, Inc).   
 Liver tissue samples for immunohistochemistry were suspended in the 
mounting media OCT (Tissue-Tek) in a tissue cassette which was submerged in 
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isopentane over a dry ice bath.  The samples were then stored at -80oC until 
sectioned. 
 Quantitative PCR (qPCR):  cDNA was synthesized from 5 µg of RNA for each 
sample using Superscript III reverse transcriptase (Invitrogen Corp).  For each RNA 
sample, a “no reverse transcriptase” (nRT) control was prepared using an equal 
volume of RNA.  For each set of reverse transcriptase reactions, a “no template” 
(nT) control was also included.  Real-time PCR (RT-PCR) was performed at 1:50 
dilutions for each cDNA synthesized and the corresponding nRT and nT controls.  
SYBR Green JumpStart Ready Mix (Sigma-Aldrich Co) with either 0.3 or 0.9 µM 
primers and 5µL of either cDNA or nRT control was used in each sample for 
quantitative analysis.  Each target was amplified in triplicate using the Rotor Gene 
3000 (Corbett Research) thermal cycler at 95oC for 3 min following 37 cycles of 94oC 
for 15 s, 54oC for 20s, and 72oC for 25s.  Following amplification, a melting curve 
analysis was performed by monitoring fluorescence while heating reactions from 50 
to 99oC in 0.2oC intervals.  All primer pairs have been validated previously (see 
Holmes 2006).  The melting curves for each sample were monitored to ensure the 
presence of a single product of the appropriate melting temperature.  In cases, 
where multiple peaks were seen, the samples were eliminated and repeated.  
Additionally, the efficiencies of the reactions were monitored, and reactions with 
efficiencies deviating more than 20% from 2.00 were eliminated.   
 The cycle at which each sample crossed the fluorescence threshold, Ct, was 
determined, and the triplicate values for each was averaged.  Any sample that did 
not exceed threshold by the 37th cycle was considered not detected (nd).  The 
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average Ct for each gene target was then normalized to EF1alpha by determining 
the ?Ct (Ct of EF1alpha - Ct of target gene).  The relative expression was then 
calculated as 2?Ct, which set the expression of EF1alpha to 1.  The experimental 
error was calculated by comparing the common variance of each Ct between the 
animals [(2%CV/100) x relative expression].   
 Immunofluorescence microscopy:  Fresh-frozen livers were sectioned at 5 
µm, and four serial sections were mounted on each slide.  Slides were stored at -
80oC.  The tissues were fixed by submerging the slides in 100% ethanol for 30 
minutes at -20oC, then washed in PBS plus 1.2 mM CaCl2 (pH 7.4).  Samples were 
submerged in a block solution (5% normal goat serum/1% bovine serum albumin in 
1x PBS, pH 7.4) for 2 hours.  Primary antibodies were diluted in block solution 
before being added to slides (antibody solutions are summarized in table 3.1).  All 
slides were stained with a rabbit polyclonal antibody raised against a claudin and co-
stained with a rat monoclonal antibody raised against ZO-1 to mark the TJ.  
Following a 2 hour incubation in primary antibody, the slides were washed in PBS 
(pH 7.4) and then incubated in secondary antibodies and DAPI for 1 hour.  Goat anti 
Rabbit Cy2 and Goat anti Rat Cy3 were diluted in block at 1:200 and 1:2000, 
respectively.  A final wash in PBS (pH7.4) and a brief wash in water were performed 
before mounting coverslips with a mowiol mounting medium.  Mounting media was 
allowed at least 24 hours to dry before viewing.   
 Two controls were also performed to verify the specificity of the antibodies.  
The specificity of antibodies recognizing claudins-2, -3, and -5 has been verified 
previously by our lab by peptide blocking with the peptides the antibodies were 
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raised against (Rahner 2001).  The specificity of the antibody for claudin-1 was 
verified using a similar peptide blocking experiment.  A 10-fold molar excess of the 
antigen-containing peptide was incubated with the primary antibody diluted in 
blocking buffer for 15 minutes before being added to slides that had been fixed and 
blocked as described above.  A control sample was also prepared without any 
antibody that recognizes s claudin but with the secondary antibody used to detect 
the claudin antibody.   
Claudin Zymed ID Concentration Dilution 
Rabbit anti claudin-1 51-9000 0.80 mg/mL 1:100 
Rabbit anti claudin-2 51-6100 0.35 mg/mL 1:100 
Rabbit anti claudin-3 34-1700 0.08 mg/mL 1:50 
Rabbit anti claudin-5 34-1600 0.125 mg/mL 1:50 
Rabbit anti claudin-7 34-9100  1:200 
Rabbit anti claudin-8 40-2600  1:100 
Rat anti ZO-1, mAb N/A  1:200 
 
 Slides were viewed using fluorescent detection on a Nikon Eclipse E800 
microscope with a 40X Oil Plan/Fluor objective, and signal was detected using a 
Hamamatsu ORCA-ER Camera.  The filter sets were as follows: for Dapi detection 
(excitation at 360-370 and emission at 400), for Cy2 detection (excitation at 470 and 
emission at 515), and for Cy3 detection (excitation at 545 and emission at 590).  All 
images were captured using metamorph and processed in Adobe Photoshop.   
RESULTS:   
 Relative expression of claudins-1 through -16 and -18 were measured using 
quantitative PCR (qPCR).  Of these claudins, claudins-4, -6, -9, -11, -13, -16, and -
18 were not detected.  Claudins-1, -2, -3, and -12 were expressed at levels roughly 
comparable with expression of occludin and ZO-1, while claudins-5, -7, -8, -14, and -
15 were expressed at significantly lower levels (Figure 3.1).  qPCR revealed a 
Table 3.1 
Antibodies used 
for liver 
immunostaining.   
All available from 
Zymed except  
ZO-1 (courtesy of 
D. Goodenough).     
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dramatic gradient in expression with, for example, claudins-1, -2, and -3 expressed 
at levels over 700-fold greater than that of claudin-7.   
Figure 3.1  Claudin transcript expression measured by qPCR.  Expression of 
claudins-1, -2, -3, -5, -7, -8, -12, 14, -15 was detected and measured relative to EF1-
alpha in mouse liver.  Claudins-4, -6, -9, -11, -13, -16, and -18 were not detected.  Y-
axis is broken between 0.0025 and 0.00025 to better show the expression of the 
claudins expressed at low levels.   
 
 Claudins expressed at levels detectable by qPCR were examined by 
immunohistochemical analysis, which revealed the localization of claudins-1, -2, -3, -
5, -7, and -8.  Antibodies raised against claudins-12, -14, and -15 were either 
unavailable or unable to detect the protein by immunohistochemical methods.   As 
mentioned above, the specificity of the antibodies recognizing claudins-2, -3, and -5 
has been documented previously (Rahner 2001).  The specificity of the claudin-1 
antibody is demonstrated by the peptide blocking experiment shown in figure 2.1a.  
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No peptides were available for the claudins-7 and -8 antibodies, but the specificity of 
these antibodies has been shown previously by immunoblot (Holmes 2006).  
Additionally, slides incubated without a rabbit anti claudin antibody but with a goat 
anti rabbit secondary showed no reactivity (figure 2.1b).  Both pictures show 
periportal hepatocytes, and to show the structure, the portal vein and bile ducts are 
labeled.   
 
Figure 3.2  Immunohistochemistry controls.  (a) incubation of claudin-1 peptide with 
claudin-1 antibody before incubation on tissue abolishes claudin-1 staining (right) 
without affecting ZO-1 (center).  Merge shows claudin-1 plus peptide in green, ZO-1 
in red, and nuclei in blue.  (b) Goat anti rabbit Cy 2 secondary alone does not reveal 
any staining in the Cy 2 channel.  BD=bile duct, PV= portal vein.       
Claudins-12, -14, and -15 were not detectable using reagents currently available.  
 For each of the claudins examined, a representative picture is presented 
showing the hepatocytes surrounding the portal triads and the central vein.  Claudin-
1 is expressed along the length of the acinus (figure 3.3), while claudin-2 is 
expressed at the pericentral end (figure 3.4).  The claudin-1 staining also shows a 
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diffuse stain in the bile duct as well as nuclear stain.  It is not clear whether this 
represents actual localization to these structures.  Claudin-3 is expressed along the 
length of the acinus as well as in the cholangiocytes (Figure 3.5).  Localization of 
claudin-5 is confined to the endothelium where expression is detected in the 
sinusoids and portal vein (Figure 3.6).  Claudins-7 and -8 are expressed in the 
cholangiocytes of the bile duct epithelium in the portal triad (Figures 3.7 and 3.8).  In 
addition, claudins-7 and -8 are expressed by large bile ducts (Figure 3.9).   
DISCUSSION:   
 As documented in other tissues, claudins show complex localization patterns 
in the liver (table 3.2).  The gradients of claudin expression along the acinus may 
indicate a gradient in paracellular resistance properties.  When expressed in cultured 
cell lines, different claudin family members confer variable properties of 
transepithelial electrical resistance (TER).  Claudin-1, which is expressed along the 
acinus, increases TER when expressed in cultured MDCK cells (McCarthy 2000, 
Inai 1999).  In contrast, claudin-2, which is expressed at the TJ of pericentral 
hepatocytes, decreases TER significantly when expressed in MDCK cells (Furuse 
2001).  The influence of claudin-3 on the properties of any cell lines is not yet known.  
The way claudins interact synergistically is not yet clear.  While the hypothesis that 
there is a TER gradient from the portal triad to central vein has not yet been tested, 
the localization patterns observed in my studies suggests the possibility of a gradient 
in paracellular transport.   
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Claudin Localization 
Claudin-1  Hepatocytes 
Claudin-2 Pericentral hepatocytes 
Claudin-3 Hepatocytes and cholangiocytes 
Claudin-5 Portal vein and Sinusoidal endothelium 
Claudin-7 Cholangiocytes 
Claudin-8 Cholangiocytes 
 
 It is difficult to hypothesize what impact claudins expressed at low levels have 
on the physiology of the liver, but in some cases it is likely that the low levels of 
mRNA expression reflect localization to specific substructures.  Claudin-5, for 
example, is expressed at relatively low levels, but its expression is confined to 
endothelial cells.  Likewise, claudins-7 and -8 are expressed at low levels but may 
still be important for paracellular transport.  Their expression is only detectable in 
cholangiocytes of bile ducts.  Cholangiocytes represent 3-5% of the total mass of the 
liver (Boyer 1996), and the relative expression of claudins-7 and -8 in cholangiocytes 
alone may represent a significant fraction of the total claudin expression within this 
cell type.   
 Claudins may do more than influence transport in the liver.  They may, for 
example, be important in cell signaling and survival.  Claudin-1 is upregulated in 
colon carcinomas and metastatic lesions, and its downregulation leads to decreases 
in invasion and tumorigenesis (Dhawan 2005).  Knockdown of claudin-1 by RNAi 
increased apoptosis by anoikis in metastatic colon cancer cell lines.  Claudin-1 may 
have similar roles in other tissues including the liver and more particularly the 
cholangiocytes.  Primary sclerosing cholangitis is associated with apoptosis of 
cholangiocytes, and claudin-1 is mutated in a neonatal sclerosing cholangitis 
(Gapany 1997, Harada 1998, Hadj-Rabia 2004).  The disease progression of the 
Table 3.2 
Summary of 
claudin 
localization in 
mouse liver.      
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claudin-1 associated sclerosing cholangitis is unknown but may involve disruptions 
of cell signaling processes rather than the epithelial barrier.   
 The TJ may also be dynamically regulated in a number of adaptive and 
disease states.  Structural changes in TJ morphology, as visible by freeze-fracture 
electron microscopy, have been documented following common bile duct ligation 
(CBDL) and estrogen-induced cholestasis in rat (Easter 1983, Rahner 1996).  
However, claudins-1, -2, and -3 were not shown to be upregulated following CBDL 
(Takakuwa 2002).  In liver regeneration following 2/3 partial hepatectomy, claudin-3 is 
reported to be upregulated 3-fold in rat (Takaki 2001), but the implications of this 
change in expression are not clear.   
 The inflammatory cytokine IL-1ß is released in inflamed rat livers following 
treatment with thioacetamide, and when cultured hepatocytes are treated with IL-1ß, 
claudin-2 levels are upregulated (Yamamoto 2004).  This claudin-2 upregulation may 
be associated with HNF1alpha, a transcription factor that has been shown to be 
involved in regulating claudin-2 expression in liver and colon in concert with other 
transcription factors including Cdx1, Cdx2, and GATA4 (Sakaguchi 2002, Escaffit 
2005).  Other transcription factors active in the liver may also be responsible for 
regulating claudin expression.  HNF4a, RXRa and RAR? are transcription factors 
which control the expression of a number of bile acid transporters and mediate both 
differentiation and expression of claudin-6 and -7 (Kubota 2001, Satohisa 2005).   
 The physiological role of claudins within the liver is still unknown but likely 
involves paracellular movement of solute to facilitate flow, electrolyte composition, 
and concentration of bile.  Additionally, claudins may be involved in cell signaling 
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events that regulate proliferation and apoptosis in the liver.  Understanding the 
control of claudins in disease states at transcriptional and post-translational levels 
will provide some insight as to the role of claudins in normal and pathological states.   
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